Gardasil royalties are about 20% of CSL's profit, and these are mooted to fall about 20%, and hence the negative impact is some 4%. The market has over reacted to the news that the USA licensee of Gardasil had lowered sales forecasts.
The foregoing arithmetic is a rough approximation, and 4% might be too high, but the thrust of what I write here is probably correct.
Pioupiou
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$241.60 |
Change
0.680(0.28%) |
Mkt cap ! $116.9B | |||
| Open | High | Low | Value | Volume |
| $240.50 | $242.88 | $240.10 | $114.7M | 474.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 539 | $241.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $241.64 | 118 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |